NNC2215, a glucose-sensitive insulin, offers improved glycemic control by dynamically adjusting to blood sugar levels, ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Postbariatric Hypoglycemia ...

and transplant interventions in patients with T1D complicated by problematic hypoglycemia (Table 2) and to propose clinical practice recommendations (Table 3) in a tiered, four-stage treatment ...

For others, more expensive treatment such as CSII with and without ... are common in patients with problematic hypoglycemia; they may only be eligible for an islet transplant.

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean ...

While insulin treatment in diabetic patients is extremely effective in lowering blood glucose from dangerous highs, the authors continued, episodes of moderate to severe hypoglycemia are common ...

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of ...

Zealand Pharma said it has received a complete response letter from the Food and Drug Administration related to its new drug application for dasiglucagon for the prevention and treatment of ...

For instance, some type 2 diabetes medications can cause hypoglycemia when taken together, so you and your doctor should also consider your current treatment if you’re adding a new medication to ...

No. 48 / 2024 Zealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism U.S. Food and Drug ...